AGEN
Agenus Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.26
+0.18%Margins
Gross margin
75.6%
EBITDA margin
117.4%
EBIT margin
27.3%
Net margin
69.3%
FCF margin
-74.2%
-46.2%
Return on equity
53.3%
Return on assets
-22.9%
Return on invested capital
0.74x
Asset turnover
-$98.5M
Cash from operations
$0.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026